Geron Newswire

Geron Newswire

Comprehensive Real-Time News Feed for Geron.

Results 1 - 20 of 161 in Geron

  1. Imetelstat Might Be Brought Down By Hy's LawRead the original story w/Photo

    7 hrs ago | Seeking Alpha

    We believe imetelstat may have a patient that meets Hy's Law, a concept that the FDA uses to judge liver toxicity. Geron's acknowledgement of patient deaths, the FDA's recent information request on safety, and a center's suspension in the imetelstat trial, in our opinion, are too much to ignore.

    Comment?

  2. The No BS Plan: Week 1 ReportRead the original story w/Photo

    9 hrs ago | Seeking Alpha

    ... was sad to see it miss the buy-back price target of 5.41, as now it looks like PGNX is going to continue accumulating. Geron Corporation ( GERN ) may have been a bit of a wildcard, as it had a slew of articles ( including my own ) presenting ...

    Comment?

  3. Geron Co. (GERN) Receives $3.75 Average Target Price from AnalystsRead the original story w/Photo

    Tuesday Feb 13 | IntersportsWire

    Shares of Geron Co. have earned an average recommendation of "Hold" from the six analysts that are covering the company, MarketBeat.com reports.

    Comment?

  4. EPS for Geron (GERN) Expected At $-0.04; Churchill Downs (CHDN) Had 3 Analysts Last WeekRead the original story w/Photo

    Tuesday Feb 13 | Hill Country Times

    Analysts expect Geron Corporation to report $-0.04 EPS on March, 7.They anticipate $0.01 EPS change or 20.00% from last quarter's $-0.05 EPS. After having $-0.04 EPS previously, Geron Corporation's analysts see 0.00% EPS growth.

    Comment?

  5. Geron (GERN) Shares Down 7%Read the original story w/Photo

    Saturday Feb 10 | IntersportsWire

    Geron Co. traded down 7% during trading on Thursday . The company traded as low as $2.40 and last traded at $2.40.

    Comment?

  6. Geron Co. (GERN) Given Consensus Rating of "Hold" by AnalystsRead the original story w/Photo

    Friday Feb 9 | AmericanBankingNews.com

    Shares of Geron Co. have been given a consensus rating of "Hold" by the six brokerages that are currently covering the company, Marketbeat.com reports.

    Comment?

  7. Geron (GERN) Trading Up -2.3%Read the original story w/Photo

    Friday Feb 9 | IntersportsWire

    Shares of Geron Co. were up 2.3% during mid-day trading on Wednesday . The stock traded as high as $2.72 and last traded at $2.56.

    Comment?

  8. Geron: Imetelstat's History Of Deaths And Safety IssuesRead the original story w/Photo

    Friday Feb 9 | Seeking Alpha

    It appears that the FDA may be investigating continued safety issues with imetelstat in its current clinical trials that may result in another clinical hold. Investors seem to have gotten excited again about the prospects for Geron's imetelstat, pushing the shares +50% year to date at its peak to nearly nine-month highs.

    Comment?

  9. Mid-Afternoon Market Update: Crude Oil Down 1.5%; Natural Grocers Shares Drop On Earnings MissRead the original story

    Friday Feb 2 | Benzinga

    ... Friday afternoon, the healthcare shares slipped by just 0.5 percent. Meanwhile, top gainers in the sector included Geron Corporation (NASDAQ: GERN ), up 9 percent, and Edwards Lifesciences Corp (NYSE: EW ), up 6 percent. In trading on Friday, energy ...

    Comment?

  10. Geron (GERN) Shares Gap Up to $2.53Read the original story w/Photo

    Friday Feb 2 | IntersportsWire

    Geron Co. gapped up prior to trading on Wednesday . The stock had previously closed at $2.61, but opened at $2.53.

    Comment?

  11. Geron (GERN) Shares Up 12.8%Read the original story w/Photo

    Tuesday Jan 30 | IntersportsWire

    Geron Co. 's share price shot up 12.8% during mid-day trading on Tuesday . The company traded as high as $2.40 and last traded at $2.65.

    Comment?

  12. Geron continues rally, up 15%Read the original story w/Photo

    Tuesday Jan 30 | Seeking Alpha

    Micro cap Geron is up again today on a 5x surge in volume. Shares have rallied ~ 35% in two days.

    Comment?

  13. Monday's ETF Movers: XBI, GDXJRead the original story

    Monday Jan 29 | MarketNewsVideo

    In trading on Monday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.2% on the day. Components of that ETF showing particular strength include shares of Geron , up about 15% and shares of Editas Medicine , up about 13.3% on the day.

    Comment?

  14. Little Geron May Soon Be Nipping At The Heels Of Celgene And IncyteRead the original story w/Photo

    Monday Jan 29 | Seeking Alpha

    Geron may be the real nightmare Celgene's investors fear and may soon become reality as Imetelstat shows superior results compared to Revlimid in Myelodysplastic Syndrome patients. While biotech giant Celgene seems to be making all the headlines lately with two multi-billion-dollar acquisitions, little biotech Geron may very well be the David to Celgene's Goliath.

    Comment?

  15. Geron Co. (GERN) Short Interest Up 7.1% in JanuaryRead the original story w/Photo

    Thursday Jan 25 | AmericanBankingNews.com

    Geron Co. was the target of a large growth in short interest in the month of January.

    Comment?

  16. Geron (GERN) Earning Somewhat Favorable Media Coverage, Report FindsRead the original story w/Photo

    Tuesday Jan 23 | IntersportsWire

    News articles about Geron have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time.

    Comment?

  17. Geron Co. (GERN) Given Consensus Rating of "Hold" by AnalystsRead the original story w/Photo

    Jan 15, 2018 | AmericanBankingNews.com

    Geron Co. has received an average rating of "Hold" from the six brokerages that are covering the company, Marketbeat reports.

    Comment?

  18. Geron (GERN) Upgraded to Sell by BidaskClubRead the original story w/Photo

    Jan 15, 2018 | Daily Political

    Several other brokerages have also recently issued reports on GERN. Needham & Company LLC restated a hold rating on shares of Geron in a report on Friday, November 3rd.

    Comment?

  19. Geron (GERN) Upgraded by BidaskClub to a oeSellaRead the original story w/Photo

    Jan 15, 2018 | The Breeze

    Several other analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Geron from a buy rating to a hold rating in a research report on Tuesday, October 10th.

    Comment?

  20. Geron (GERN) Rating Increased to Sell at BidaskClubRead the original story w/Photo

    Jan 14, 2018 | AmericanBankingNews.com

    Several other equities analysts have also recently issued reports on GERN. Needham & Company LLC reiterated a "hold" rating on shares of Geron in a research note on Friday, November 3rd.

    Comment?